1. Home
  2. IVCA vs COYA Comparison

IVCA vs COYA Comparison

Compare IVCA & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVCA
  • COYA
  • Stock Information
  • Founded
  • IVCA 2021
  • COYA 2020
  • Country
  • IVCA Cayman Islands
  • COYA United States
  • Employees
  • IVCA N/A
  • COYA N/A
  • Industry
  • IVCA Blank Checks
  • COYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • IVCA Finance
  • COYA Health Care
  • Exchange
  • IVCA Nasdaq
  • COYA Nasdaq
  • Market Cap
  • IVCA 93.8M
  • COYA 98.5M
  • IPO Year
  • IVCA 2022
  • COYA 2022
  • Fundamental
  • Price
  • IVCA $11.82
  • COYA $6.41
  • Analyst Decision
  • IVCA
  • COYA Strong Buy
  • Analyst Count
  • IVCA 0
  • COYA 4
  • Target Price
  • IVCA N/A
  • COYA $16.25
  • AVG Volume (30 Days)
  • IVCA 301.0
  • COYA 93.4K
  • Earning Date
  • IVCA 01-01-0001
  • COYA 03-18-2025
  • Dividend Yield
  • IVCA N/A
  • COYA N/A
  • EPS Growth
  • IVCA N/A
  • COYA N/A
  • EPS
  • IVCA 0.26
  • COYA N/A
  • Revenue
  • IVCA N/A
  • COYA $9,554,315.00
  • Revenue This Year
  • IVCA N/A
  • COYA N/A
  • Revenue Next Year
  • IVCA N/A
  • COYA $56.22
  • P/E Ratio
  • IVCA $45.87
  • COYA N/A
  • Revenue Growth
  • IVCA N/A
  • COYA N/A
  • 52 Week Low
  • IVCA $11.10
  • COYA $4.75
  • 52 Week High
  • IVCA $12.37
  • COYA $10.69
  • Technical
  • Relative Strength Index (RSI)
  • IVCA 41.74
  • COYA 52.07
  • Support Level
  • IVCA $11.81
  • COYA $5.85
  • Resistance Level
  • IVCA $12.03
  • COYA $7.25
  • Average True Range (ATR)
  • IVCA 0.02
  • COYA 0.51
  • MACD
  • IVCA -0.01
  • COYA -0.04
  • Stochastic Oscillator
  • IVCA 5.26
  • COYA 32.94

About IVCA Investcorp India Acquisition Corp.

Investcorp AI Acquisition Corp is a blank check company.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Share on Social Networks: